Paul Tudor Jones Taro Pharmaceutical Industries LTD Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$27.6 - $32.99 $205,095 - $245,148	7,431 New	7,431 $216,000
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $202,700 - $221,106	-2,885 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $203,334 - $230,655	2,885 New	2,885 $213,000
Q4 2018 Feb 14, 2019	SELL	$78.25 - $107.92 $258,225 - $356,136	-3,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$97.82 - $116.09 $322,806 - $383,097	3,300 New	3,300 $324,000
Q1 2018 May 15, 2018	SELL	$95.91 - $107.26 $443,967 - $496,506	-4,629 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$104.5 - $126.38 $95,304 - $115,258	-912 Reduced 16.46%	4,629 $485,000
Q3 2017 Nov 14, 2017	BUY	$97.26 - $116.2 $538,917 - $643,864	5,541	5,541 $624,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.